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Brain multiplexes reveal 
morphological connectional 
biomarkers fingerprinting late  
brain dementia states
Ines Mahjoub1,2, Mohamed Ali Mahjoub2, Islem Rekik  1 & Alzheimer’s Disease Neuroimaging 
Initiative*
Accurate diagnosis of mild cognitive impairment (MCI) before conversion to Alzheimer’s disease 
(AD) is invaluable for patient treatment. Many works showed that MCI and AD affect functional and 
structural connections between brain regions as well as the shape of cortical regions. However, ‘shape 
connections’ between brain regions are rarely investigated -e.g., how morphological attributes such 
as cortical thickness and sulcal depth of a specific brain region change in relation to morphological 
attributes in other regions. To fill this gap, we unprecedentedly design morphological brain multiplexes 
for late MCI/AD classification. Specifically, we use structural T1-w MRI to define morphological 
brain networks, each quantifying similarity in morphology between different cortical regions for a 
specific cortical attribute. Then, we define a brain multiplex where each intra-layer represents the 
morphological connectivity network of a specific cortical attribute, and each inter-layer encodes the 
similarity between two consecutive intra-layers. A significant performance gain is achieved when using 
the multiplex architecture in comparison to other conventional network analysis architectures. We 
also leverage this architecture to discover morphological connectional biomarkers fingerprinting the 
difference between late MCI and AD stages, which included the right entorhinal cortex and right caudal 
middle frontal gyrus.
Alzheimer Disease (AD) is one of the most devastating neurodegenerative diseases, affecting memory as well as 
cognitive functions of the human brain. With the absence of immediate treatment for patients diagnosed with 
AD, an accurate diagnosis of AD in an earlier stage propels early clinical interventions that could help slow down 
irreversible cognitive decline. Specifically, an intermediate stage exists between AD and normal control (NC) 
which is Mild Cognitive Impairment (MCI), where unlike AD, the memory deficits in MCI patients may remain 
relatively stable for years. The MCI stage is regarded as very critical as patients can still benefit from adequate 
clinical interventions before conversion to AD.
Considering the increasing number of brain imaging datasets on dementia and particularly AD, several 
methods based on neuroimaging processing and machine-learning have been developed in the purpose of early 
detection of AD conversion at the MCI stage. Hence, detecting brain biomarkers in the stage of MCI may allow 
the individualization of effective treatment to demented patients. Remarkably, the majority of these methods 
have extensively relied on resting state functional and diffusion magnetic resonance imaging (MRI)1–8. Some 
works proposed brain network analysis methods using noninvasive diffusion MRI for AD diagnosis, where struc-
tural connectivities were measured using the degree of white matter connectivity between the associated pairs 
of ROIs4,8. On the other hand, several studies used functional brain networks which mostly focused on char-
acterizing the pairwise correlation (e.g., Pearson Correlation) between ROIs. Recently, more advanced studies 
proposed novel functional connectivity (FC) representations to model brain networks at different connectional 
levels. For example, Yu et al. proposed a novel method to construct brain FC by taking advantage of both Pearson 
Correlation and sparse learning1. While some works only used high-order FC3 considering the relationships 
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between pairs of ROIs, more recent studies integrated both low-order and high-order FC networks along with 
interactions between the two levels7. However, analysis of functional networks is typically limited by the choice 
of a single or multiple thresholds for examining network topology, which may discard many important and dis-
criminative brain connectivities. Moreover, while functional MRI can produce spurious and noisy connectomes, 
diffusion MRI can produce biased and largely variable structural connectomes depending on the employed fiber 
tractography method9. Besides, both structural and functional modalities are rarely acquired in a conventional 
clinical routine. Additionally, distinguishing between late MCI (LMCI) patients, who might be on the verge to 
convert to AD, and AD patients is a much more challenging classification task than that of AD vs. NC or early 
MCI (EMCI) vs. AD. Due to the very subtle brain changes between LMCI and AD brain changes, LMCI/AD clas-
sification task remains a hard problem to solve, that has been hardly addressed in the AD literature10,11.
On the other hand, many other studies have demonstrated the importance of considering cortical measures 
derived from the multi-folded surface of the cerebral cortex for AD diagnosis, such as the cortical thickness12–15. 
Specifically, cortical thickness is considered as a biomarker of AD progression, which provides insight into nor-
mal brain development and neurodegenerative disorders since it is correlated with changes in cognitive perfor-
mance15–18. For instance, Frisoni et al. showed reduction in cortical thickness in AD subjects compared with 
control subjects15. Thus, many voxel-based methods16,17 or region-based methods18 heavily relied on morpho-
logical features, including volumetric cortical thickness measurements from MRI, for AD diagnosis. However, 
all these methods were based on volumetric cortical thickness analysis, while there is evidence that AD alters not 
only volume-based cortical measures, but also the shape of cortical regions -e.g., cortical thinning at different 
levels19. For this reason, other studies explored cortical thickness using surface-based methods involving spec-
tral shape description20, or combining shape-derived features with voxel features21,22. However, these approaches 
considered the morphological features at only the vertex-level. To the best of our knowledge, none of existing 
network-based analysis methods for disentangling late AD states investigated the morphological connectivities 
between ROIs using structural T1-w MRI-i.e., modeling how the morphology of different brain regions may be 
affected in relation to one another. Moreover, since AD may affect the complex relationships between a set of 
attributes in different cortical regions, one cannot rely on a single cortical attribute to examine how the brain is 
progressively altered by different stages of AD. A more comprehensive approach would consider multiple cortical 
attributes (e.g., sulcal depth, cortical thickness), each of these representing a single view of cortex morphology to 
quantify brain morphology. In this paper, we propose the first multi-view morphological brain connectivity using 
four different cortical attributes: cortical thickness network, sulcal depth network, average curvature network, 
and principal curvature network. Then, based on this multi-view connectional representation of brain morphol-
ogy, we further propose novel network architecture that would allow us to investigate the complex relationship 
between these views for identifying late MCI morphological connectional biomarkers distinguishing between 
LMCI and AD.
Typically, the majority of network-based methods developed for MCI/AD classification diagnosis overlooked 
the high-order relationship between different brain connectional layers. A few recent network-analysis works 
proposed for classification tasks between different AD stages (e.g., early MCI, late MCI), used one-layer net-
work representation23, a multi-layer (i.e. set of concatenated networks) network24 or high-order networks10,11. 
Specifically, the recently proposed high-order functional connectivity networks for MCI/AD diagnosis23 inte-
grated new high-level features that encode how different brain region pairs, instead of two brain regions, func-
tionally interact with each other. Nevertheless, it will be possible to further consider other new connections 
through exploring how different network pairs interact with each another (and not only brain region pairs). This 
nicely led us to the concept of a multiplex network, which was historically coined to indicate the presence of more 
than one relationship between the same actors of a social network25. Some previous methods26–30 have explored 
multiplexes to study brain networks (e.g., structural, functional). These multiplex networks (or multiplexes) allow 
multiple types of relationships to be represented in modelling brain connectivities, thus capturing higher levels 
of complexity between brain regions. However, all the mentioned studies investigated multiplex as a multi-layer 
network without exploring similarity networks that encode the relationship between consecutive brain connec-
tivity layers. For instance, Battiston et al. used multiplexes as a two-layer network (functional and anatomical) 
to extract brain subgraphs while overlooking the inter-layer that perform high-order connectivities27. Moreover, 
these approaches either relied on fMRI, combine fMRI with structural MRI, or used different modalities such as 
MRI with PET26; but none explored morphological brain network each based on a specific attribute of the cortical 
surface, with the notable exception of recent works31,32 targeting early dementia and autism spectrum disorder 
diagnosis.
To address this limitation, we further propose a morphological brain multiplex interleaving a set of two 
different layers: an intra-layer which represents the morphological connectivity network of a specific cortical 
attribute, and an inter-layer (or a similarity layer) which computes the Pearson Correlation between two con-
secutive intra-layers. The proposed architecture leverages both morphological networks and the correlational 
relationship between each two consecutive layers. However, different similarity networks can be extracted by 
varying the order of layers. Hence, we define an ensemble of morphological brain multiplexes, each capturing 
complex network-to-network relationships for predefined set of cortical attributes by reordering at each time 
different intra-layers, with the exception of the first intra-layer, to capture new similarity networks. We aim by this 
architecture to discover morphological connectional biomarkers distinguishing between AD and LMCI patients, 
which can be clinically useful for early detection of AD conversion at MCI stage.
Results
Data processing and parameters. In our study, we used 77 subjects (41 AD and 36 LMCI) from ADNI 
GO public dataset, each with structural T1-w MR image33. Data used in the preparation of this article were 
obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). The ADNI 
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was launched in 2003 as a public-private partnership, led by Principal Investigator Michael W. Weiner, MD. The 
primary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission 
tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined 
to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD). We used 
FreeSurfer processing pipeline34 to reconstruct both right (RH) and left (LH) cortical hemispheres for each sub-
ject from T1-w MRI35. Then we parcellated each cortical hemisphere into 35 cortical regions using Desikan-
Killiany cortical atlas35. Using FreeSurfer pipeline, each vertex on the cortical surface was assigned four cortical 
attributes: maximum principal curvature, cortical thickness, sulcal depth, and average curvature.
For the deep similarity network architecture, we used two levels (l = 0, l = 1). We defined K = 6 multiplexes 
using 4 cortical attributes, where multiplex 1  includes morphological networks generated using different corti-
cal attributes {N1, N2, N3, N4}, 2  includes {N1, N2, N4, N3}, 3 includes {N1, N3, N4, N2}, 4  includes {N1, N3, N2, 
N4}, 5  includes {N1, N4, N2, N3}, and 6  includes {N1, N4, N3, N2}. For each cortical region, N1 denotes the mean 
maximum principal curvature, N2 denotes the mean cortical thickness, N3 denotes the mean sulcal depth and N4 
denotes the mean of average curvature.
Data distribution. Table 1 displays the gender/age distribution for both AD and LMCI groups. Both groups 
were matched in gender and age.
Comparison methods. We compared our proposed architectures with two conventional methods: (1) 
one-layer network architecture, and (2) concatenated multi-layer network architecture. For the first baseline 
method, we used the designed M morphological brain networks. For the second baseline method, we constructed 
the multi-layer network through concatenating all morphological networks in a large network  = ..N N{ , , }M1  
of size R × R × M (R = 35, M = 4).
Evaluation. We evaluated our framework through varying the number of Kf selected features from 180 to 
250 by adding 10 features at each evaluation step (Fig. 1). We noted that for the majority of the selected fea-
tures’ dimensions, the deep similarity architecture increased the classification performance in comparison with 
AD LMCI
M 23 20
F 18 16
Total 41 36
Mean age 75.27 72.54
Std age 8.72 6.10
Table 1. Data distribution. M: male. F: female. Total: total number of subjects in each group. Std: standard 
deviation.
Figure 1. Influence of the selected features number on the accuracy of both baseline and proposed methods. 
(A) and (B) plot the accuracy curves against the number of selected features for deep similarity network 
compared with baseline methods for RH and LH, respectively. (C) and (D) plot the accuracy curves against the 
number of selected features for the 6 proposed multiplexes of right and left hemispheres respectively.
www.nature.com/scientificreports/
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the conventional methods (i.e., one-layer network and concatenated 4-layer network), for both left and right 
hemispheres. Remarkably, the classification accuracies highly improved when using particular brain multiplexes. 
Table 2 displays the average classification accuracies for baseline methods as well as for the proposed architec-
tures. The best average accuracy was achieved by multiplex 6 (respectively including {N1, N4, N3, N2} cortical 
attributes as intra-layers) for LH (68.61%), while it was achieved by multiplex 5 (respectively including {N1, N4, 
N2, N3} cortical attributes as intra-layers) for RH (72.25%).
Notably, the best accuracies were obtained using a number of features equal to 220 and 210 for RH and LH, 
respectively (Fig. 2). When using one-layer morphological networks, the classification accuracy only reached 
63.64% for LH and 66.23% for RH. These classification results decreased when concatenating features extracted 
from all morphological networks (level 0), as the classification rate was limited to 59.74% for RH and 58.44% for 
LH. However, when we further integrated the similarity networks between all pairs of layers in the proposed deep 
similarity network architecture (level 1), the performance significantly increased for both RH (67.53%) and LH 
(64.94%) compared to one-layer network and concatenated one-layer networks architectures. For both hemi-
spheres, the highest accuracies were achieved using multiplex 6 , multiplex 5, and multiplex 1 . Specifically, 
ACC SEN SPE
LH RH LH RH LH RH
Layer A1 57.69 61.15 56.59 57.73 58.53 67.37
Layer A2 59.74 51.35 55.21 41.91 66.76 50.55
Layer A3 49.43 66.47 47.22 63.39 51.22 66.46
Layer A4 47.18 40.34 43.40 41.27 50.30 41.86
A1 − A4 59.03 61.51 55.90 59.02 61.89 63.10
Deep similarity 65.32 64.84 67.70 68.05 63.71 66.15
Multiplex 1 65.06 71.42 66.32 75.00 65.54 71.95
Multiplex 2 65.70 68.47 68.40 66.66 64.02 72.25
Multiplex 3 66.38 66.58 69.09 61.68 65.24 69.20
Multiplex 4 63.61 66.47 65.97 67.36 62.49 64.93
Multiplex 5 61.93 72.25 56.25 72.56 66.76 74.39
Multiplex 6 68.61 70.95 73.61 74.65 65.45 74.08
Table 2. LMCI/AD average classification accuracy for the proposed morphological network architectures by 
varying the number of top selected features from 180 to 250, with an incremental step of 10 features. ACC: 
accuracy. SEN: sensitivity. SPE: specificity.
Figure 2. Best performances reached respectively by right hemisphere RH and left hemisphere LH, using 
different architecture networks. ‘A’ denotes cortical attribute, ‘DS’ denotes deep similarity, and ‘M’ denotes 
Multiplex.
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multiplex 6  achieved the best accuracy among all architecture networks with a classification accuracy peaking 
at 77.92% for RH and 71.43% for LH. This shows that the proposed similarity networks allow to better discrimi-
nate between LMCI and AD subjects. This was also reflected by the percentages of discriminative features belong-
ing to the similarity inter-layer networks for each multiplex as shown in Table 3. We note that for some 
multiplexes, more than 50% of Kf discriminative features lied in the network inter-layers -i.e., similarity 
networks.
Identified morphological connectional biomarkers for LMCI/AD classification. We further 
explored our multiplex architecture and morphological networks to identify morphological connectional bio-
markers that discriminate between LMCI and AD patients. Since we aimed to find the most discriminative mor-
phological connections, we chose the brain multiplex with the highest discriminative power. For LH, we found 
that the discriminative power of multiplex 6  was the most reproducible since it gave the best average accuracy 
across different numbers of selected features as well as the best accuracy (for Kf = 210) in comparison with all 
other network architectures. As for RH, multiplex 5  achieved the best mean average across different numbers 
of selected features, while we noted the highest accuracy reached by multiplex 6 for a number of features equal 
to 220. Hence, we selected multiplex 6  achieving the best accuracies for both hemispheres to discover morpho-
logical connectional biomarkers, using the specific number of discriminative features 220 (77.92%) and 210 
(71.43%) for RH and LH, respectively.
In Fig. 3, we visualized using circular graphs the top most frequently selected morphological brain connectiv-
ities in multiplex 6 . Circular graphs were plotted for the top 10, 15 and 20 discriminative features, respectively. 
The thickness of each edge connecting a pair of ROIs represents the normalized rank of the discriminative brain 
connection. The most discriminative connections with the highest normalized ranks have thick edges, while 
those with less discriminative power have thinner edges. Blue edges denote connections belonging to a multiplex 
inter-layer, while red edges denote connections falling into a multiplex intra-layer.
We noted that 20% (resp. 50%) of the top 10 discriminative features were located in the multiplex inter-layers 
for RH (resp. LH). Using the normalized ranks, the most discriminative connectional features for RH connected 
the Entorhinal Cortex (EC) (region 6) and the Caudal Middle Frontal Gyrus (CMFG) (region 3), EC and 
Temporal Pole (TP) (region 33), EC and Frontal Pole (FP) (region 32), EC and Bank of the Superior Temporal 
Sulcus (BSTS) (region 1) and the fifth connectivity was between the Paracentral Lobule (PL) (region 17) and 
Caudal Anterior-cingulate Cortex (CAC) (region 2), respectively. As for the LH, the most discriminative features 
connected the EC and the Rostral Middle Frontal Gyrus (RMFG) (region 27), EC and Lingual Gyrus (LG) (region 
13), EC and Postcentral Gyrus (region 22), EC and CAC, and PL and Precentral Gyrus (region 24), respectively. 
We noted that the most discriminative morphological hub node in multiplex 6  for both hemispheres was the 
entorhinal cortex, where the top four discriminative connections with the highest normalized ranks branched 
from it.
Besides, even when we increased the number of discriminative features from 10 to 20, new connectivities 
appeared, most of them emerged from the EC. Moreover, the percentage of the top discriminative features 
belonging to inter-layers was low for RH (~15%) compared to LH (~45%). We also note that the majority of the 
most discriminative morphological brain connections fell into the 5th layer (A3), which represents the mean sulcal 
depth attribute (Tables 4 and 5).
More importantly, while most discriminative features belonging to intra-layers emerged from EC for both 
left and right hemispheres, those belonging to inter-layers emerged from the fusiform gyrus and the paracentral 
lobule for RH. The same regions were present in LH with new other hub nodes including the precentral gyrus, 
transverse temporal cortex, rostral anterior cingulate cortex, and isthmus-cingulate cortex.
Discussion
We proposed a novel representation of brain connectivity to identify connectional biomarkers based on the mor-
phology of the cerebral cortex for distinguishing between late mild cognitively impaired patients and Alzheimer’s 
disease patients. In this study, we unprecedentedly investigated the role of several morphological connectivity 
networks as well as the correlation between them to discover morphological connectional brain biomarker finger-
printing the difference between LMCI and AD states. In particular, we proposed two brain architectures: the deep 
similarity network and the multiplex network. While in the first architecture we simply concatenated all possible 
similarity networks with the main morphological network, in the second one we constructed similarity networks 
only between successive layers, and generated different multiplexes by reordering the morphological layers.
% of intra-layers % of inter-layers
LH RH LH RH
Multiplex 1 54.12 59.44 45.88 40.56
Multiplex 2 50.27 35.52 49.73 64.74
Multiplex 3 43.66 39.59 56.34 60.41
Multiplex 4 38.15 51.75 61.85 48.24
Multiplex 5 42.00 56.00 58.00 44.00
Multiplex 6 53.54 62.77 46.45 37.23
Table 3. Percentage of discriminative features belonging to the similarity inter-layers and the intra-layers for 
each of the proposed multiplexes.
www.nature.com/scientificreports/
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Our proposed architectures achieved better performances than one-layer morphological network and concat-
enated 4-layer networks. This shows that the aggregation of different similarities between morphological brain 
connections helps better discriminate between AD and LMCI patients compared to using a single morpholog-
ical network or even all morphological networks without exploring their relationships (Fig. 2). Moreover, our 
multiplex architecture achieved the highest accuracies, which indicates that the similarity inter-layers between 
morphological networks are able to capture a higher-level discriminative information. This demonstrates that 
disease-driven changes in the cortical shape quantified using a specific cortical attribute can be also influenced by 
shape changes measured using a different cortical attribute.
Through using different cortical attributes and identifying the most of discriminative features by multiplex 
6, we found that the mean sulcal depth has the highest discriminative power (Tables 4 and 5). Sulcal depth has 
been identified in the literature as one of the quantitative measures of cerebral cortex, representing an important 
morphological biomarker for AD36,37. Im et al. presented a surface-based method that investigated changes of 
sulcal shape in MCI and AD, using sulcal depth and average mean curvature36. They showed that the progression 
of disease from NC to MCI and MCI to AD was coupled with shallowness in sulcal depth. The same finding37 was 
Figure 3. Most discriminative morphological cortical network connections between LMCI and AD for RH and 
LH, respectively.
Rank First region Second region Layer
1 Entorhinal Cortex Caudal Middle Frontal Gyrus Mean sulcal depth
2 Temporal Pole Entorhinal Cortex Mean sulcal depth
3 Frontal Pole Entorhinal Cortex Mean sulcal depth
4 Entorhinal Cortex Bank of the superior Temporal Sulcus Mean sulcal depth
5 Paracentral Lobule Caudal interior cingulate cortex Similarity between mean sulcal depth and mean maximum principal curvature
6 Entorhinal Cortex Unmeasured Corpus Callosum Mean sulcal depth
7 Medial Orbital Frontal Cortex Entorhinal Cortex Mean sulcal depth
8 Paracentral Lobule Fusiform Gyrus Mean sulcal depth
9 Pericalcarine Cortex Entorhinal Cortex Mean sulcal depth
10 Superior Frontal Gyrus Entorhinal Cortex Mean sulcal depth
Table 4. Top 10 discriminative morphological connections in the cortex with their corresponding layers for the 
right hemisphere.
www.nature.com/scientificreports/
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replicated by Yun et al., which proposed an automated sulcal depth measurement on cortical surface and high-
lighted that mean sulcal depth in MCI was lower than in NC.
The most discriminative morphological connectivities with the highest normalized ranks were established 
between EC and CMFG for RH, and EC and RMFG for LH. Many studies highlighted that RMFG is a discriminative 
region in AD diagnosis as well as CMFG38. It was also noted that about 18% of the CMFG atrophies in AD patients38.
One of the major findings of our study is the detection of morphological brain connectional biomarkers fin-
gerprinting the distinction between LMCI and AD dementia brain states. We found that 85% (resp. 65%) of most 
RH (resp. LH) discriminative regions connected to the EC fingerprint LMCI/AD classification (Fig. 3). The EC 
has a major role in working memory processing39–43. Its importance was revealed due to its anatomical intercon-
nection with the hippocampus, which is the major region responsible of memory formation43,44. EC role consists 
of generating coding schemes for new memories and storing them temporarily. It has numerous reciprocal con-
nections with the hippocampus, specifically an effective connectivity in the hippocampus strongly depends on 
the connectivity among EC layers45.
Our findings based on cortical morphological connectivity were in line with previous studies, since the 
EC has been considered as a good biomarker for AD and MCI in the literature46–50. It has a great potential for 
detecting early memory decline and is considered as the region of early neurodegeneration caused by dementia. 
Velayudhan et al. examined the relationship between EC thickness, hippocampal volume and the whole brain 
volume, and showed that AD patients have thinner EC thickness and smaller hippocampal volume compared 
with MCI subjects46. The same hypothesis about the role of EC was demonstrated by the work of Thaker et al.47, 
which considered EC thickness as a marker of medial temporal and neocortical AD neuropathology. The review 
paper48 also highlighted the early EC atrophy detection as an important anatomical marker for MCI and AD, 
since it was remarkably highly correlated with the early pathological changes in AD. Besides, greater changes in 
the right EC were present compared with the left one, which substantiates our results, since we achieved the best 
multiplex-based LMCI/AD classification performance using the right hemisphere.
Our study has a few limitations. First, although we used different types of morphological attributes, we simply 
concatenated all derived connectivities to extract features without creating fused predictors of disease diagnosis. 
Second, though we identified key morphological connectional biomarkers for LMCI stage, mainly involving the 
entorhinal cortex, we did not investigate the connection of the discovered cortical regions to other non-cortical 
regions (e.g., EC to hippocampus). It is still not clear how the shape-based morphological connectivities of EC can 
be altered with the hippocampus connectivities such as functional or structural. Third, since MCI is a progressive 
disease, tracking the discriminative power of the identified morphological biomarkers can help better understand 
how the morphology of a specific discriminative region (e.g., EC thickness) gets altered progressively with time in 
cognition in relation to other cortical attributes42,44. Fourth, although the structural underpinning of morpholog-
ical networks remains unclear, the co-vary brain regions were suggested as a result of mutually trophic influences 
or common experience related plasticity51,52. In particular, it was noted that the pattern of cortical thickness corre-
lation of certain brain regions is similar to the underlying fiber connections from DTI tractography53. Gong et al. 
also pointed out that approximately 35–40% convergent connections exist between brain networks using thick-
ness and diffusion measurements, which suggests that thickness correlations include exclusive information54.
In our future work, we will investigate longitudinal morphological connectivities to improve our framework as 
well as longitudinal morphological changes in the EC. Besides, we will use advanced methods for different mor-
phological and similarity networks fusion55 while integrating other multimodal brain networks (e.g., resting-state 
functional networks and structural diffusion networks) into our proposed brain multiplex architectures26.
Methods
We first introduce our morphological brain network construction strategy from structural T1-w MRI. Then, we 
propose two different architectures to explore the relationship between multiple brain connectivity morphological 
Rank First region Second region Layer
1 Rostral Middle Frontal Gyrus Entorhinal Cortex Mean sulcal depth
2 Lingual Gyrus Entorhinal Cortex Mean sulcal depth
3 Postcentral Gyrus Entorhinal Cortex Mean sulcal depth
4 Entorhinal Cortex Caudal Anterior-Cingulate Cortex Similarity between mean maximum principal curvature and mean of average curvature
5 Precentral Gyrus Paracentral Lobule Similarity between mean of average curvature and mean sulcal depth
6 Transverse Temporal Cortex Rostral Anterior Cingulate Cortex Similarity between mean of average curvature and mean sulcal depth
7 Entorhinal Cortex Cuneus Cortex Mean sulcal depth
8 Entorhinal Cortex Caudal Middle Frontal Gyrus Similarity between mean maximum principal curvature and mean of average curvature
9 Rostral Anterior Cingulate Cortex Entorhinal Cortex Similarity between mean maximum principal curvature and mean of average curvature
10 Entorhinal Cortex Unmeasured Corpus Callosum Mean sulcal depth
Table 5. Top 10 discriminative morphological connections in the cortex with their corresponding layers for the 
left hemisphere.
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views: (1) a deep multi-level similarity network that aggregates different morphological brain networks with hier-
archical combinations of similarity networks between them; and (2) morphological brain multiplex network, 
which is defined through inserting additional inter-layers between the aggregated networks. Last, we perform 
feature extraction and selection to classify a testing subject, and morphological biomarker identification. Figure 4 
displays the key steps of the proposed framework.
Morphological Brain Network Definition. Following the cortical surface parcellation into R anatomical 
regions, for each ROI Ri, we average the cortical attribute a across all vertices v in Ri as follows:
∑
∈ ∈v R
a v1
#{ }
( ),
i v Ri
where #{v∈Ri} denotes the number of vertices v belonging to ROI Ri, and a(v) the cortical attribute value assigned 
to vertex v. Ultimately, to define the morphological connection Na(i,j) in network Na between ROIs Ri and Rj, we 
compute the absolute difference between averaged cortical attributes in both ROIs:
∑ ∑=
∈
−
∈
.
∈ ∈{ }N i j v R a v v R a v( , )
1
#{ }
( ) 1
#
( )a
i v R j v Ri j
Given R cortical regions in each hemisphere, the size of each fully connected morphological network is R × R. We 
note that according to our definition, as two ROIs Ri and Rj become more similar in morphology, Na(i, j) tends 
to 0.
Proposed Morphological Network Architectures. To extract relevant and high-order morphological 
features from a set of M morphological cortical brain networks {N1, .., NM}, each encoding a specific shape attrib-
ute of the cortical surface, we propose ‘simple-to-complex’ strategies for building network architectures that cap-
ture different characteristics of how these networks interact with one another. In particular, high-order network 
architectures aim to reflect how these networks are nested with respect to one another in a high dimensional 
manifold of networks.
Proposed deep similarity network architecture construction. We first propose a deep multi-level 
network architecture, where each level integrates the similarity networks between all pairs of networks in the 
previous level. The relationship between pairs of networks is defined by the measure of Pearson correlation 
(Fig. 5A). Thus, we define the degree of correlation between different cortical networks at each level. The baseline 
level (l = 0) is composed of all concatened networks N N{ , , }M
0
1
0 0 = .. . To build the next level, we create a larger 
multi-layer network through concatenating ns similarity networks, where = = −n C M M!/( 2)!2!s M
2 , represent-
ing the number of possible pairwise combinations between M networks. This produces a new deeper network 
  ∪= … … −{ }S S S, , ,pq M M1 0 1,2 1, , where p and q represent the indices of two different networks in 0 . For 
brevity, we note the baseline network at a specific level l as = …N N{ , , }l l M
l
1 l , where Ml represents the total 
number of level l networks. Hence, in the next level (l + 1), we consider l  as the baseline network, and add the 
similarity networks at a specific level l + 1 as:  = … …+ −{ }S S S, , ,l pq M M1 1,2 1,l l , where Spq represents the similar-
ity network between networks N p
l  and Nq
l. From level to level, we gradually add similarity networks between 
networks in the previous level (including similarity networks), thereby producing deeper networks from one level 
to the next one, where N N Sl l l1 1∪=+ +  (Fig. 5C). The deep multi-level similarity network architecture is thus 
constructed in a hierarchical way, which captures not only network-to-network similarities, but also 
‘similarity-to-similarity’ similarities.
Proposed ensemble multiplex network architecture construction. Although the proposed deep 
similarity network architecture allows to explore similarities between networks at different hierarchical levels, this 
aggregates the similarity networks at the end of previous multi-layer network, in an agglomerative manner with-
out enabling us to take account into the most correlated pairs of morphological networks. To enforce a more 
structured design of networks and their similarities, we propose to use a multiplex network to model the 
inter-relations between different layers. In a generic way, we define a brain multiplex  as a set of M intra-layers 
{N1, .., NM} (i.e., morphological networks), where between two consecutive layers Ni and Nj, we slide an inter-layer 
Si,j. This yields to following multiplex architecture: N S N N S N N{ , , , , , , , , }i i j j M1 1,2 2 ,= … …  (Fig. 5B). Unlike 
the previous architecture (Fig. 5C), we note that for a specific multiplex, we are only allowed to explore similarities 
between consecutive layers. We also use Pearson Correlation to generate inter-layers as the deep similarity net-
work architecture. Hence, to explore the inter-relationship between all possible combinations of layers for each 
subject, we generate K multiplexes through simply reordering the intra-layer networks while fixing the first 
intra-layer, thereby generating an ensemble of multiplexes   { , , }K1= … . Each of these multiplexes captures 
specific similarities between different kinds of morphological networks (e.g., sulcal depth network and cortical 
thickness network) that may not be present in another brain multiplex.
Network feature extraction and selection for classification. For each of the proposed subject-specific 
network architectures in the previous section, we perform feature extraction, selection and LMCI/AD classifica-
tion as follows.
www.nature.com/scientificreports/
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Feature extraction. To explore the discriminative power of each region-to-region morphological connectivity 
in the cortex, we directly use the weights of edges in the morphological network as connectional brain features.
Since the constructed morphological connectivity matrix (or network Na) is symmetric (Fig. 4A), connec-
tional features are extracted for each subject through concatenating the weights of all connectivities in each trian-
gular matrix. Of note, for each network of size R × R, we extract a feature vector of size (R(R − 1)/2). For the deep 
similarity network and multiplex architectures, we extract features from each network in the architecture, then 
Figure 4. Illustration of AD/LMCI classification framework steps for the proposed cortical morphological 
network architectures. (A) We generate different morphological networks, each derived from a specific attribute 
of the cortical surface shape. (B) For each multi-layer network, we extract features from the triangular part of 
each cortical connectivity matrix. (C) For feature selection, we use IFS strategy (Roffo et al.56), then we train a 
linear support vector machine classifier using the selected connectional features.
Figure 5. Proposed deep similarity network and multiplex network architectures, with illustration of the 
similarity network construction step. (A) We generate the similarity network between two morphological 
attribute networks by computing Pearson Correlation between them. (B) We construct the multiplex 
architecture where each inter-layer is a similarity network. (C) We consider the inter-relations between  l 
networks through progressively concatenating, from a previous level l to a current level (l + 1), all possible 
similarity networks between pairs of networks.
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concatenate them all together into a high-dimensional feature vector. For a network architecture comprising Mn 
networks, the size of the final feature vector is Mn × (R(R − 1)/2).
Feature selection and classification. Due to the high-dimensionality of the extracted feature vectors and the small 
number of data samples, feature selection is a key step in classification tasks to both reduce the dimension of the 
training feature vectors and single out the most discriminative features. To this aim, we train a support vector 
machine (SVM) classifier using leave one-out cross-validation (LOO-CV) strategy. Given P subjects, we apply 
Infinite Feature Selection (IFS)56 in a supervised manner using the (P − 1) training subjects to select the top Kf 
features that significantly distinguish LMCI from AD patients. The most frequently selected features across dif-
ferent cross-validation schemes represent the morphological connectional biomarkers that allow to distinguish 
between AD and LMCI patients.
IFS method is a filter-based algorithm that aims to avoid over-fitting in a high-dimensional data by not con-
sidering irrelevant and/or redundant features. Compared with other feature selection methods, IFS has a com-
pelling aspect that allows to efficiently identify reliable distinctive features for classification tasks. Most feature 
selection methods, which rank and select features, evaluate the importance of each feature individually, usually 
by neglecting potential interactions among the elements of the joint set. However, IFS performs joint ranking 
with selection and the score attributed for each feature in influenced by all other features. The idea is based on 
building a graph for the feature distribution, where the vertices denote the features and the edges represent the 
pairwise relationships among the feature distribution. Then, the algorithm ranks different morphological features 
by their importance and discriminative power. It evaluates the importance of a given feature while considering 
all the possible subsets of features. Given the output indices of the ranked features, we select the top Kf ranked 
features to train a linear SVM classifier using LOO-CV strategy to assign a label (LMCI or AD) to a new testing 
subject (Fig. 4C).
Identification of morphological connectional biomarker. To identify morphological connectional biomarkers, we 
select the top nf indices of Kf discriminative features ranked by IFS56 across all PLOO-CV. Specifically, we generate 
a matrix of size nf × P, where each row represents the top ranked indices of features and each column represents 
a specific rank. For a given feature fk, we calculate its normalized rank across different LOO-CV as follows: 
δ= ∑ ∑= =( )r f w f P( ) ( ) /k iP jn ij ij k1 1f , where δij = 1 if fk is selected, δij = 0 otherwise. The weight wij(fk) denotes the cor-
responding weight of feature fk assigned by IFS, at the ith LOO and jth rank. Next, we identify the connectional 
biomarkers as features with the top normalized ranks.
Availability of materials and data. The data that support the findings of this study are available from 
ADNI data (http://adni.loni.usc.edu/). For reproducibility and comparability, the authors will make available 
upon request all morphological networks generated based on the four cortical attributes (maximum principal 
curvature, cortical thickness, sulcal depth, and average curvature) for 77 subjects (41 AD and 36 LMCI) following 
the approval by ADNI Consortium. The Matlab code for generating an ensemble of multiplexes using M brain 
networks for a single subject (e.g., morphological, structural, or functional) is also available from the authors 
upon request.
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